Liberty Biopharma Inc (CVE:LTY – Get Free Report)’s share price crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares changing hands.
Liberty Biopharma Price Performance
The stock has a market capitalization of C$21.54 million and a P/E ratio of -12.66. The firm has a 50-day moving average price of C$2.00 and a 200 day moving average price of C$2.00. The company has a debt-to-equity ratio of 8.19, a quick ratio of 0.12 and a current ratio of 0.12.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Further Reading
- Five stocks we like better than Liberty Biopharma
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Darden Stock Up After Q4 Earnings Beat, Cautious FY25 Outlook
- How to Calculate Inflation Rate
- Celsius Stock: Why Piper Sandler Forecasts a 50% Surge
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Accenture’s Stock Earnings Reveal an AI-Powered Growth Strategy
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.